CFLAR and endometrial carcinoma: Dolcet et al. provided evidence that TRAIL resistance in endometrial carcinoma cells is caused by elevated Cellular FADD-like IL-1β-converting enzyme (FLICE)-inhibitory protein (c-FLIP) levels [120] which are regulated by CK2 [121].